{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:21Z","timestamp":1776329841945,"version":"3.50.1"},"reference-count":11,"publisher":"Baskent University","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.6002\/ect.2017.0178","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T02:08:11Z","timestamp":1529374091000},"page":"47-51","source":"Crossref","is-referenced-by-count":3,"title":["Conversion From Steroid to Everolimus in Maintenance Kidney Transplant Recipients With Posttransplant Diabetes Mellitus"],"prefix":"10.6002","volume":"17","author":[{"name":"the Surgical Branch, Institute of Kidney Diseases, Jichi Medical University Hospital, Shimotsuke, Japan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nanmoku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Shinzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"issue":"8","key":"ref0","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1111\/ajt.12313","article-title":"Association between steroid dosage and death with a functioning graft after kidney transplantation","volume":"13","author":"Opelz","year":"2013","unstructured":"1.\tOpelz G, Dohler B. Association between steroid dosage and death with a functioning graft after kidney transplantation. Am J Transplant. 2013;13(8):2096-2105.","journal-title":"Am J Transplant"},{"issue":"10","key":"ref1","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1097\/01.TP.0000140969.43761.1F","article-title":"Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials","volume":"78","author":"Pascual","year":"2004","unstructured":"2.\tPascual J, Quereda C, Zamora J, Hernandez D, Spanish Group for Evidence-Based Medicine in Renal T. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation. 2004;78(10):1548-1556.","journal-title":"Transplantation"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-6143.2007.02057.x","article-title":"A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients","volume":"8","author":"Vincenti","year":"2008","unstructured":"3.\tVincenti F, Schena FP, Paraskevas S, et al. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant. 2008;8(2):307-316.","journal-title":"Am J Transplant"},{"issue":"6","key":"ref3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/1744-9987.12378","article-title":"An overview of regular dialysis treatment in Japan (as of 31 December 2013)","volume":"19","author":"Masakane","year":"2015","unstructured":"4.\tMasakane I, Nakai S, Ogata S, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2013). Ther Apher Dial. 2015;19(6):540-574.","journal-title":"Ther Apher Dial"},{"issue":"10","key":"ref4","first-page":"SS3","article-title":"New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.","volume":"75","author":"Davidson","year":"2003","unstructured":"5.\tDavidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003;75(10 Suppl):SS3-24.","journal-title":"Transplantation","ISSN":"https:\/\/id.crossref.org\/issn\/0041-1337","issn-type":"print"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1523-1755.2002.kid582.x","article-title":"Impact of post-transplant diabetes","volume":"62","author":"Cosio","year":"2002","unstructured":"6.\tCosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int. 2002;62(4):1440-1446.","journal-title":"Kidney Int"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.trre.2015.09.001","article-title":"Everolimus immunosuppression in kidney transplantation: What is the optimal strategy","volume":"30","author":"Witzke","year":"2016","unstructured":"7.\tWitzke O, Sommerer C, Arns W. Everolimus immunosuppression in kidney transplantation: What is the optimal strategy? Transplant Rev (Orlando). 2016;30(1):3-12.","journal-title":"Transplant Rev (Orlando)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"American Diabetes A. Diagnosis and classification of diabetes mellitus.","volume":"33","year":"2010","unstructured":"8.\tAmerican Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1:S62-69.","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","unstructured":"9.\tMatsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982-992.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"ref9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \"EZR\" for medical statistics","volume":"48","author":"Kanda","year":"2013","unstructured":"10.\tKanda Y. Investigation of the freely available easy-to-use software \"EZR\" for medical statistics. Bone Marrow Transplant. 2013;48(3):452-458.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"ref10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.diabres.2015.09.014","article-title":"mTOR inhibitors and diabetes","volume":"110","author":"Verges","year":"2015","unstructured":"11.\tVerges B, Cariou B. mTOR inhibitors and diabetes. Diabetes Res Clin Pract. 2015;110(2):101-108.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T07:56:11Z","timestamp":1549439771000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/forms\/ectrxcontentshow.php?doi_id=10.6002\/ect.2017.0178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2017.0178","relation":{},"ISSN":["1304-0855"],"issn-type":[{"value":"1304-0855","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}